0000950170-23-046430.txt : 20230905
0000950170-23-046430.hdr.sgml : 20230905
20230905163606
ACCESSION NUMBER: 0000950170-23-046430
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230901
FILED AS OF DATE: 20230905
DATE AS OF CHANGE: 20230905
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Duke William E.
CENTRAL INDEX KEY: 0001636135
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40703
FILM NUMBER: 231236324
MAIL ADDRESS:
STREET 1: C/O VALERITAS, INC., 750 ROUTE 202 SOUTH
STREET 2: SUITE 600
CITY: BRIDGEWATER
STATE: NJ
ZIP: 08807
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Invivyd, Inc.
CENTRAL INDEX KEY: 0001832038
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 851403134
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1601 TRAPELO ROAD
STREET 2: SUITE 178
CITY: WALTHAM
STATE: MA
ZIP: 02451
BUSINESS PHONE: (781) 819-0080
MAIL ADDRESS:
STREET 1: 1601 TRAPELO ROAD
STREET 2: SUITE 178
CITY: WALTHAM
STATE: MA
ZIP: 02451
FORMER COMPANY:
FORMER CONFORMED NAME: Adagio Therapeutics, Inc.
DATE OF NAME CHANGE: 20201112
4
1
ownership.xml
4
X0508
4
2023-09-01
0001832038
Invivyd, Inc.
IVVD
0001636135
Duke William E.
C/O INVIVYD, INC.
1601 TRAPELO ROAD, SUITE 178
WALTHAM
MA
02451
false
true
false
false
Chief Financial Officer
false
Stock Option (Right to Buy)
1.83
2023-09-01
4
A
false
750000
0
A
2033-08-31
Common Stock
750000
750000
D
This option vests over a four-year period, with 25% of the shares subject to the option vesting on the first anniversary of the grant date of September 1, 2023 and the remaining 75% of the shares subject to the option vesting over the subsequent three-year period in substantially equal monthly installments at a rate of 1/48th of the total shares subject to the option each month, subject to the Reporting Person's continuous service as of each vesting date.
/s/ Jill Andersen attorney-in-fact for William E. Duke
2023-09-05